Mild therapeutic hypothermia (MTH) is used to lower the core body temperature of cardiac arrest (CA) patients to 32°C from 34°C to provide improved survival and neurologic outcomes after resuscitation from in-hospital or out-of-hospital CA. Despite the improved benefits of MTH, there are potentially unforeseen complications associated during management. Although the adverse effects are transient, the clinician should be aware of the associated complications when managing the patient receiving MTH. We aim to provide the medical community comprehensive information related to the potential complications of survivors of CA receiving MTH, as it is imperative for the clinician to understand the physiologic changes that take place in the patient receiving MTH and how to prepare for them and manage them if they do occur. We hope to provide information of how to manage these potential complications through both a review of the current literature and a reflection of our own experience.
BernardSAGrayTWBuistMD. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Eng J Med. 2002;346(8):557–563.
2.
ZeinerAHolzerMSterzF. Mild resuscitative hypothermia to improve neurological outcome after cardiac arrest. a clinical feasibility trial. hypothermia after cardiac arrest (HACA) study group. Stroke. 2000;31(1):86–94.
3.
StormCSteffenISchefoldJC. Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls. Crit Care. 2008;12(3):R78.
4.
Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549–556.
5.
LundbyeJBRaiMRamuB. Therapeutic hypothermia is associated with improved neurologic outcome and survival in cardiac arrest survivors of non-shockable rhythms. Resuscitation. 2012;83(2):202–207.
6.
BartelsMTjanDHReussenEMvan ZantenAR. Therapeutic hypothermia after prolonged cardiopulmonary resuscitation for pulseless electrical activity. Neth J Med. 2007;65(1):38–41.
7.
TestoriCSterzFBehringerW. Mild therapeutic hypothermia is associated with favourable outcome in patients after cardiac arrest with non-shockable rhythms. Resuscitation. 2011;82(9):1162–1167.
8.
NagaoK. Therapeutic hypothermia following resuscitation. Curr Opin Crit Care. 2012;18(3):239–245.
9.
NolanJPMorleyPTHoekTL. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the international liaison committee on resuscitation. Circulation. 2003;57(3):231–235.
10.
DumasFGrimaldiDZuberB. Is hypothermia after cardiac arrest effective in both shockable and nonshockable patients?: insights from a large registry. Circulation. 2011;123(8):877–886.
11.
GajicOFesticEAfessaB. Infectious complications in survivors of cardiac arrest admitted to the medical intensive care unit. Resuscitation. 2004;60(1):65–69.
12.
MongardonNDumasFRicomeS. Postcardiac arrest syndrome: from immediate resuscitation to long-term outcome. Ann Intensive Care. 2011;1(1):45.
13.
NegovskyVA. Postresuscitation disease. Crit Care Med. 1988;16(10):942–946.
14.
NeumarRWNolanJPAdrieC. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. a consensus statement from the international liaison committee on resuscitation (American heart association, Australian and New Zealand council on resuscitation, European resuscitation council, heart and stroke foundation of Canada, InterAmerican heart foundation, resuscitation council of Asia, and the resuscitation council of Southern Africa); the American heart association emergency cardiovascular care committee; the council on cardiovascular surgery and anesthesia; the council on cardiopulmonary, perio-perative, and critical care; the council on clinical cardiology; and the stroke council. Circulation. 2008;118(23):2452–2483.
15.
ArrichJHolzerMHerknerHMüllnerM. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev. 2009;(4):CD004128.
16.
HolzerM. Targeted temperature management for comatose survivors of cardiac arrest. N Engl J Med. 2010;363(13):1256–1264.
17.
WattsDDTraskASoekenK. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma. 1998;44(5):846–854.
18.
JurkovichGGreiserWLutermanACurreriP. Hypothermia in trauma victims: an ominous predictor of survival. J Trauma. 1987;27(9):1019–1024.
19.
ElderingSAragonGMooreE. Fatal hepatic hemorrhage after trauma. Am J Surg. 1979;138(6):883–887.
20.
WolfrumSPierauCRadkePWSchunkertHKurowskiV. Mild therapeutic hypothermia in patients after out-of-hospital cardiac arrest due to acute ST-segment elevation myocardial infarction undergoing immediate percutaneous coronary intervention. Crit Care Med. 2008;36(6):1780–1786.
21.
TumaMAStansburyLGSteinDM. Induced hypothermia after cardiac arrest in trauma patients: a case series. J Trauma. 2011;71(6):1524–1527.
22.
ValeriCRMacGregorHCassidyGTinneyRPompeiF. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit Care Med. 1995;23(4):698–704.
23.
SpielAOKliegelAJanataA. Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids. Resuscitation. 2009;80(7):762–765.
24.
MichelsonADMacGregorHBarnardMRKestinASRohrerMJValeriCR. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost. 1994;71(5):633–640.
25.
DodsonJAWangYChaudhrySICurtisJP. Bleeding avoidance strategies and outcomes in patients ≥80 years of age with st-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the NCDR CathPCI registry). Am J Cardiol. 2012;110(1):1–6.
26.
MartiniWZPusateriAEUscilowiczJMDelgadoAVHolcombJB. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma. 2005;58(5):1002–1009.
27.
MartiniWZ. The effects of hypothermia on fibrinogen metabolism and coagulation function in swine. Metabolism. 2007;56(2):214–221.
28.
MartiniWZHolcombJB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg. 2007;246(5):831–835.
29.
MartiniWZCortezDSDubickMAParkMSHolcombJB. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma. 2008;65(3):535–543.
30.
BernardSBuistMMonteiroOSmithK. Induced hypothermia using large volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital cardiac arrest: a preliminary report. Resuscitation. 2003;56(1):9–13.
31.
NgKFLamCCChanLC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth. 2002;88(4):475–480.
32.
SundeKPytteMJacobsenD. Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation. 2007;73(1):29–39.
33.
SpauldingCMJolyLMRosenbergA. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336(23):1629–1633.
34.
NielsenNHovdenesJNilssonF. Hypothermia network. outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthesiol Scand. 2009;53(7):926–934.
35.
SchefoldJCStormCJoerresAHasperD. Mild therapeutic hypothermia after cardiac arrest and the risk of bleeding in patients with acute myocardial infarction. Int J Cardiol. 2008;132(3):387–391.
36.
MongardonNPerbetSLemialeV. Infectious complications in out-of-hospital cardiac arrest patients in the therapeutic hypothermia era. Crit Care Med. 2011;39(6):1359–1364.
37.
KimuraASakuradaSOhkuniHTodomeYKurataK. Moderate hypothermia delays proinflammatory cytokine production of human peripheral blood mononuclear cells. Crit Care Med. 2002;30(7):1499–1502.
38.
HolzerMBernardSAHachimi-IdrissiS. Hypothermia for neuroprotection after cardiac arrest: systematic review and individual patient data meta-analysis. Crit Care Med. 2005;33(2):414–418.
39.
PerbetSMongardonNDumasF. Early onset pneumonia after cardiac arrest: characteristics, risk factors and influence on prognosis. Am J Respir Crit Care Med. 2011;184(9):1048–1054.
40.
CombesA. Early-onset pneumonia after cardiac arrest: an unintended consequence of therapeutic hypothermia?Am J Respir Crit Care Med. 2011;184(9):1048–1054.
41.
NielsenNSundeKHovdenesJ. Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med. 2011;39(1):57–64.
42.
PatelNNairSUGowdP. Central line associated blood stream infection related to cooling catheter in cardiac arrest survivors undergoing therapeutic hypothermia by endovascular cooling. Conn Med. 2013;77(1):35–41.
43.
EmpeyPEMillerTMPhilbrickAHMelickJAKochanekPMPoloyacSM. Mild hypothermia decreases fentanyl and midazolam steady-state clearance in a rat model of cardiac arrest. Crit Care Med. 2012;40(4):1221–1228.
44.
PoldermanKHPeerdemanSMGirbesAR. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg. 2001;94(5):697–705.
45.
PoldermanKHHeroldI. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med. 2009;37(3):1101–1120.
46.
PoldermanKH. Application of therapeutic hypothermia in the intensive care unit. opportunities and pitfalls of a promising treatment modality, part 2. practical aspects and side effects. Intensive Care Med. 2004;30(5):757–769.
47.
FerraraAMacArthurJDWrightHKModlinIMMcMillenMA. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg. 1990;160(5):515–518.
48.
KsanenTSkrifvarsMBVarpulaT.Strict versus moderate glucose control after resuscitation from ventricular fibrillation.Intensive Care Med. 2007;33(12): 2093–2100.
49.
KohtACaneRCerulloLJ. Serum potassium levels during prolonged hypothermia. Intensive Care Med.1983;9(5):275–277.
50.
TamaiTKagiyamaS. Studies of cat heart muscle during recovery after prolonged hypothermia. Hyperpolarization of cell membranes and its dependence on the sodium pump with electrogenic characteristics. Circ Res. 1968;22(3):423–433.
51.
GlitschH. Activation of the electrogenic sodium pump in guinea-pig auricles by internal sodium ions. J Physiol. 1972;220(3):565–582.
52.
FirminRKBoulouxPAllenPLimaRCLincolnJC. Sympathoadrenal function during cardiac operations in infants with the technique of surface cooling, limited cardiopulmonary bypass, and circulatory arrest. J Thorac Cardiovasc Surg. 1985;90(5):729–735.
53.
TeragawaHKatoMYamagataTMatsuuraHKajiyamaG. The preventive effect of magnesium on coronary spasm in patients with vasospastic angina. Chest. 2000;118(6):1690–1695.
54.
ZhouJPoloyacSM. The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function. Expert Opin Drug Metab Toxicol. 2011;7(7):803–816.
55.
TortoriciMAKochanekPMPoloyacSM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007;35(9):2196–2204.
56.
FukuokaNAibikiMTsukamotoT. Biphasic concentration change during continuous midazolam administration in brain-injured patients undergoing therapeutic moderate hypothermia. Resuscitation. 2004;60(2):225-230.
57.
LeslieKSesslerDIBjorkstenARMoayeriA. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg. 1995;80(5):1007–1014.
58.
FritzHGHolzmayrMWalterBMoeritzKULuppABauerR. The effect of mild hypothermia on plasma fentanyl concentration and biotransformation in juvenile pigs. Anesth Analg. 2005;100(4):996–1002.
59.
RokaAMelindaKTVasarhelyiBMachayTAzzopardiDSzabóM. Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics. 2008;121(4):e844-e849.
60.
HeierTCaldwellJESharmaMLGruenkeLDMillerRD. Mild intraoperative hypothermia does not change the pharmacodynamics (concentration-effect relationship) of vecuronium in humans. Anesth Analg. 1994;78(5):973–977.
61.
BeaufortAMWierdaJMBelopavlovicMNederveenPJKleefUWAgostonS. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur J Anaesthesiol Suppl. 1995;11:95–106.
62.
BakerWLGeronilaGKallurR. Effect of neuromuscular blockers on outcomes in patients receiving therapeutic hypothermia following cardiac arrest. Analg Resusc Curr Res. 2013;S1: doi: 10.4172/2324-903X.S1-001.
63.
SanjeevNULundbyeJB. The occurrence of shivering in cardiac arrest survivors undergoing therapeutic hypothermia is associated with a good neurologic outcome. Resuscitation. 2013;84(5):626–629.
64.
IidaYNishiSAsadaA. Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics. Ther Drug Monit. 2001;23(3):192–197.
65.
LiuXBorooahMStoneJChakkarapaniEThoresenM. Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. Pediatrics. 2009;124(1):310–315.
66.
MeadowsTABhattDL. Clinical aspects of platelet inhibitors and thrombus formation. Circ Res.2007;100(9):1261-1275.
67.
WrightRSAndersonJLAdamsCD. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non–st-segment elevation myocardial infarction (updating the 2007 guideline): a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the American college of emergency physicians, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2011;57(19):1920–1959.
68.
PoldermanKHK. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37(7 suppl):S186–S202.
69.
RodenDMSteinCM. Clopidogrel and the concept of high-risk pharmacokinetics. Circulation. 2009;119(16):2127–2130.
70.
HogbergCErlingeDBraunOO. Mild hypothermia does not attenuate platelet aggregation and may even increase ADP-stimulated platelet aggregation after clopidogrel treatment. Thromb J. 2009;7:2.
71.
RothGJCalverleyDC.Aspirin, platelets, and thrombosis: theory and practice. Blood. 1994;83(4);885–898.
72.
FrelingerALFurmanMIKruegerLABarnardMRMichelsonAD. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation. Circulation. 2001;104(12):1374–1379.
73.
KhanJNPrasadNGlancyJM. QTc prolongation during therapeutic hypothermia: are we giving it the attention it deserves?Europace. 2010;12(2):266–270.
74.
NishiyamaNSatoTAizawaYNakagawaSKankiH. Extreme QT prolongation during therapeutic hypothermia after cardiac arrest due to long QT syndrome. Am J Emerg Med. 2012;30(4):638.e5–e8.
75.
LebiedzPMeinersJSamolA. Electrocardiographic changes during therapeutic hypothermia. Resuscitation. 2012;83(5):602–606.
76.
MirzoyevSAMcLeodCJBunchTJBellMRWhiteRD. Hypokalemia during the cooling phase of therapeutic hypothermia and its impact on arrhythmogenesis. Resuscitation. 2010;81(12):1632–1636.
77.
LewisMEAl-KhalidiAHTownendJNCooteJBonserRS. The effects of hypothermia on human left ventricular contractile function during cardiac surgery. J Am Coll Cardiol. 2002;39(1):102–108.
KernKBHilwigRWRheeKHBergRA. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol. 1996;28(1):232–240.
80.
WeisserJMartinJBispingE. Influence of mild hypothermia on myocardial contractility and circulatory function. Basic Res Cardiol. 2001;96(2):198–205.
81.
JacobshagenCPelsterTPaxA. Effects of mild hypothermia on hemodynamics in cardiac arrest survivors and isolated failing human myocardium. Clin Res Cardiol. 2010;99(5):267–276.
82.
PatelSJTapperEBCutlipDE. Clinical pearls regarding Prinzmetal's angina complicated by cardiac arrest–management during therapeutic hypothermia. Int J Cardiol. 2012;159(1):55–57.
83.
MazièresGJrSouteyrandGEschalierRGuérinRMotreffP. A cardiac arrest: when recommended mild therapeutic hypothermia reveals the mechanism*. Crit Care Med. 2012;40(3):976–978.
84.
YamashinaYYagiTNamekawaA. Ventricular fibrillation caused by coronary artery spasm during mild therapeutic hypothermia after resuscitation. Am J Emerg Med. 2013;31(2):453.e5–e8.
85.
GodfraindTEglemeCAI OaschieI. Role of endothelium in the contractile response of rat aorta to alpha-adrenoceptor agonists. Clin Sci. 1985;68 suppl10:65s–71s.
86.
NolanJPNeumarRWAdrieC. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. a scientific statement from the international liaison committee on resuscitation; the American heart association emergency cardiovascular care committee; the council on cardiovascular surgery and anesthesia; the council on cardiopulmonary, perioperative, and critical care; the council on clinical cardiology; the council on stroke. Resuscitation. 2008;79(3):350–379.
87.
SkulecRKovarnikTDostalovaG. Induction of mild hypothermia in cardiac arrest survivors presenting with cardiogenic shock syndrome. Acta Anaesthesiol Scand. 2008;52(2):188–194.
88.
HovdenesJLaakeJHAabergeLHaugaaHBuggeJF. Therapeutic hypothermia after out-of-hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol Scand. 2007;51(2):137–142.
89.
BayJNunnJFPrys-RobertsC. Factors influencing arterial PO2 during recovery from anaesthesia. Br J Anaesth. 1968;40(6):398–407.
90.
GautierHBonoraMRemmersJE. Effects of hypoxia on metabolic rate of conscious adult cats during cold exposure. J Appl Physiol. 1989;67(1):32–38.
91.
MokhtaraniMMahgoubANMoriokaNDoufasAGSesslerDI. Buspirone and meperidine synergistically reduce the shivering threshold. Anesth Analg. 2001;93(5):1233–1239.
92.
De WitteJSesslerDI. Perioperative shivering: physiology and pharmacology. Anesthesiology. 2002;96(2):467–484.
93.
KurzMBelaniKGSesslerDI. Naloxone, meperidine, and shivering. Anesthesiology. 1993;79(6):1193–1201.
94.
KurzAIkedaTSesslerDI. Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold. Anesthesiology. 1997;86(5):1046–1054.
95.
ChamorroCBorralloJMRomeraMASilvaJABalandínB. Anesthesia and analgesia protocol during therapeutic hypothermia after cardiac arrest: a systematic review. Anesth Analg. 2010;110(5):1328–1335.
96.
RittenbergerJCPopescuABrennerRPGuyetteFXCallawayCW. Frequency and timing of nonconvulsive status epilepticus in comatose post-cardiac arrest subjects treated with hypothermia. Neurocrit Care. 2012;16(1):114–122.
97.
NielsenNSundeKHovdenesJ. Hypothermia network. Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med.2011;39(1):57–64.
RossettiAOOddoMLiaudetLKaplanPW. Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia. Neurology. 2009;72(8):744–749.
100.
Lopez-de-SaEReyJRArmadaE. Hypothermia in comatose survivors from out-of-hospital cardiac arrest: pilot trial comparing 2 levels of target temperature. Circulation. 2012;126(24):2826–2833.
